Ekso Bionics Holdings, Inc.
EKSO
$3.49
$0.010.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.13% | 15.69% | -6.19% | 38.42% | 42.88% |
| Total Depreciation and Amortization | -5.04% | -6.90% | -7.87% | -4.01% | -7.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -359.86% | -139.69% | 466.90% | -115.86% | -16.47% |
| Change in Net Operating Assets | 99.54% | 178.78% | -103.06% | 64.55% | -376.86% |
| Cash from Operations | -28.99% | 43.31% | 9.53% | 32.09% | 8.03% |
| Capital Expenditure | -- | -25.00% | 51.16% | 52.94% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -25.00% | 51.16% | 52.94% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.32% | -- | -- |
| Issuance of Common Stock | 1,874.47% | -3.22% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 332.45% | -3.50% | -190.23% | -- | -- |
| Foreign Exchange rate Adjustments | 166.67% | 131.82% | -55.00% | -- | 275.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.50% | 869.57% | -38.49% | 171.42% | 1.89% |